Company Filing History:
Years Active: 2025
Title: Kristen Jean Vallieu: Innovator in Human Alpha-Galactosidase Variants
Introduction
Kristen Jean Vallieu is a notable inventor based in Las Vegas, NV (US). She has made significant contributions to the field of biotechnology, particularly in the development of engineered human alpha-galactosidase polypeptides.
Latest Patents
Kristen holds 1 patent for her invention titled "Human alpha-galactosidase variants." This invention provides engineered human alpha-galactosidase polypeptides and compositions that have been optimized for various therapeutic applications. The engineered polypeptides exhibit improved thermostability, serum stability, and enhanced cellular uptake. They also maintain stability under both acidic and basic conditions, reduce immunogenicity, and improve the removal of globotriaosylceramide from cells.
Career Highlights
Kristen is currently associated with Crosswalk Therapeutics, Inc., where she continues to advance her research and innovations in the field. Her work focuses on developing therapeutic solutions that leverage her patented technology.
Collaborations
Some of her notable coworkers include William Casey Hallows and Nikki Dellas, who contribute to the collaborative efforts at Crosswalk Therapeutics, Inc.
Conclusion
Kristen Jean Vallieu's innovative work in human alpha-galactosidase variants showcases her commitment to advancing biotechnology for therapeutic purposes. Her contributions are paving the way for new treatments and improved patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.